FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for dextroamphetamine sulfate from SpecGx LLC under an Abbreviated New Drug Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

SUPPL AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)